Imipramine blue sensitively and selectively targets FLT3-ITD positive acute myeloid leukemia cells

by Jonathan Metts, Heath L. Bradley, Zhengqi Wang, Neil P. Shah, Reuben Kapur, Jack L. Arbiser, Kevin D. Bunting
Published 2017-06-01

Pimozide and Imipramine Blue Exploit Mitochondrial Vulnerabilities and Reactive Oxygen Species to Cooperatively Target High Risk Acute Myeloid Leukemia

by Zhengqi Wang, Tian Mi, Heath L. Bradley, Jonathan Metts, Himalee Sabnis, Wandi Zhu, Jack Arbiser, Kevin D. Bunting
Published 2021-06-01

Case Report: A Novel Pathogenic Missense Mutation in FAS: A Multi-Generational Case Series of Autoimmune Lymphoproliferative Syndrome

by Claudia L. Gaefke, Jonathan Metts, Donya Imanirad, Daime Nieves, Paola Terranova, Gianluca Dell'Orso, Eleonora Gambineri, Maurizio Miano, Richard F. Lockey, Jolan Eszter Walter, Jolan Eszter Walter, Emma Westermann-Clark, Emma Westermann-Clark
Published 2021-03-01

Primary Immunodeficiency in Children With Autoimmune Cytopenias: Retrospective 154-Patient Cohort

by Emma Westermann-Clark, Emma Westermann-Clark, Cristina Adelia Meehan, Anna K. Meyer, Anna K. Meyer, Joseph F. Dasso, Joseph F. Dasso, Devendra Amre, Maryssa Ellison, Bhumika Patel, Marisol Betensky, Marisol Betensky, Charles Isaac Hauk, Jennifer Mayer, Jonathan Metts, Jennifer W. Leiding, Jennifer W. Leiding, Panida Sriaroon, Panida Sriaroon, Ambuj Kumar, Irmel Ayala, Irmel Ayala, Jolan E. Walter, Jolan E. Walter, Jolan E. Walter
Published 2021-04-01